ロード中...
Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilization
Plerixafor, a recently approved peripheral blood progenitor cell mobilizing agent, is often added to granulocyte-colony stimulating factor (G-CSF) to mobilize peripheral blood progenitor cells in patients with lymphoma or myeloma who cannot mobilize enough CD34+ cells with G-CSF alone to undergo aut...
保存先:
主要な著者: | , , , , , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
2013
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3935820/ https://ncbi.nlm.nih.gov/pubmed/23749720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23499 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|